Article
EGF receptor mutations in lung cancer: from humans to mice and maybe back to humans.
Cancer cell - 1 Jun 2006
Arteaga Carlos L
Abstract excerpt
Deletions in exon 19 and nucleotide substitutions in exon 21 are the most common mutations of the EGFR (ErbB1) in NSCLC. These mutations endow the receptor with constitutive kinase activity. Most tumors expressing these mutants respond well to EGFR tyrosine kinase inhibitors, suggesting that they are dependent on mutant EGFR signaling. Two groups developed transgenic mice in which expression of these mutants is...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
